Sunshine Biopharma, Inc.

SBFM
$0.47 (-28.9%)
08:00 PM · May 14 · NASDAQ

Sunshine Biopharma, Inc.

SBFM
Bitcoin Treasury Stock · NASDAQ · Pointe-Claire, CA
$0.47 (-28.9%)
08:00 PM · May 14, 2026
Market Cap
$2.3M
Enterprise Value
-$4.61M
Next Earnings
Aug 17, 2026

Market Overview

Market Cap
Shares Outstanding
50-Day Moving Average
200-Day Moving Average
Average Volume (20 Days)
Beta (5Y)
  • Chart chart view
  • Table table view
  • Price
  • Market Cap MCap
  • Shares
Start Date
start date
to
End Date
start date
Date OPEN HIGH LOW CLOSE VWAP VOLUME %CHG $CHG
1D
5D
1M
3M
6M
YTD
1Y
5Y

Sunshine Biopharma, Inc. Company Overview

Sunshine Biopharma, Inc. (NASDAQ: SBFM) is a pharmaceutical and nutritional-supplement company focused on the research and development of anticancer drugs and anti-coronavirus treatments. The company is developing Adva-27a (a podophyllotoxin-derivative anticancer drug targeting leukemia, lymphoma, and various solid tumors, including multidrug-resistant cancer cells) and SBFM-PL4 (an anti-coronavirus compound), alongside selling Essential 9 nutritional supplements. Sunshine Biopharma holds Bitcoin on its corporate balance sheet as part of a digital asset treasury strategy.

Sunshine Biopharma, Inc. website url Visit Website Sunshine Biopharma, Inc. twitter url
Stock Exchange NASDAQ
IPO Date 2022-02-15
Number of Employees 52
Headquarters Pointe-Claire, QC, CA

Key Executives

Malek Chamoun

Chief Development Officer
Malek Chamoun linkedin Malek Chamoun twitter

Michel Roy

Chief Commercial Officer
Michel Roy linkedin Michel Roy twitter

Steve N. Slilaty

Chairman, President & Chief Executive Officer
Steve N. Slilaty linkedin Steve N. Slilaty twitter

Camille Sebaaly

CFO, Secretary & Director
Camille Sebaaly linkedin Camille Sebaaly twitter

Robert G. Ferreira

President of Sunshine Bio Investments Inc
Robert G. Ferreira linkedin Robert G. Ferreira twitter

Featured Posts

View all articles

Press Releases

No press releases found.

Unlock Multi-Year Historical Data & Advanced Metrics
Professional subscribers get exclusive access to advanced data and tools designed to give them an edge in the market.
Multi-year historical data Data source URLs Custom index builder AI quarterly summaries Search & filter tools
View Plans — $29/mo

SEC Filings

Form Type Filed Accepted Source

SBFM Frequently Asked Questions

The next earnings report date for Sunshine Biopharma, Inc. (SBFM) is scheduled for August 17, 2026. Stay up to date with ’s financial results and key announcements by visiting our Earnings Tracker or by subscribing to earnings alerts. Here we also provide SBFM earnings call summaries and transcripts.

The current stock price of Sunshine Biopharma, Inc. (SBFM) is $0.47 as of 08:00 PM 14/05/26. For live stock updates and company rankings, view our Bitcoin mining stocks by market cap table.

The latest news for Sunshine Biopharma, Inc. (SBFM) includes Sunshine Biopharma Reports Fiscal 2025 Revenue of $36.3 Million, a 4.1% Increase Over Prior Year published on April 6, 2026. For more details and ongoing updates, visit the SBFM news section.